Millennium Management
AMED

Millennium Management’s Amedisys AMED Stock Holding History

Millennium Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200,000
Closed -$18.2M – 5811
2024
Q4 		$18.2M Buy
+200,000
New +$18.4M 0.01% 1606
2022
Q4 		– Sell
-30,000
Closed -$2.9M – 6545
2022
Q3 		$2.9M Buy
+30,000
New +$3.58M ﹤0.01% 3420
2017
Q4 		– Sell
-50,000
Closed -$2.8M – 3766
2017
Q3 		$2.8M Buy
+50,000
New +$2.64M ﹤0.01% 1994

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's AMED Position: Q3 2025 in Review

Millennium Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 441,684 shares — an estimated $43.5M sold.

Millennium Management first reported a position in AMED in Q3 2013 and held it in 47 quarters. The position peaked at $113M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Millennium Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Millennium Management sold 441,684 Amedisys shares in Q3 2025, an estimated $43.5M.
  • Millennium Management first reported a position in Amedisys in Q3 2013 and held it in 47 quarters.
  • Millennium Management's Amedisys position peaked at $113M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.